Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. - sprookjes - yvandenbroek - TriplyDB

Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.

Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q34297241

about

Evidence for pharmacist care in the management of hypertension The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update Adherence to Antihypertensive Therapy.Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension Cost-effectiveness of pharmacist care for managing hypertension in Canada A coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's community hypertension care: study protocol for a randomized controlled trial The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials Pharmacist intervention for blood pressure control: medication intensification and adherence.Will Team-Based Care Really be Implemented?Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge.Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial.Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.Evaluating the impact of pharmacist health education on the perceptions of the pharmacist's role among women living in a homeless shelter.The Role of Care Management as a Population Health Intervention to Address Disparities and Control Hypertension: A Quasi-Experimental Observational Study.Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring.Pharmacist-Driven Strategies for Hypertension Management in Los Angeles: A Community and Stakeholder Needs Assessment, 2014-2015.Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.Clinical Pharmacist Team-Based Care in a Safety Net Medical Home: Facilitators and Barriers to Chronic Care Management.Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care: Study Protocol.An introduction to the fundamentals of randomized controlled trials in pharmacy research.Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans.Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population.The ultimate opportunity for advancing pharmacy practice.Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis.Role of clinical pharmacist in the management of blood pressure in dialysis patients.The impact of clinical pharmacists in improving Jordanian patients' health outcomes.Collaborative care model for hypertension.Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation.Effectiveness of pharmacist's intervention in the management of cardiovascular diseases.Indonesian pharmacists' and pharmacy students' attitudes towards collaboration with physicians.Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.Optimizing pharmacotherapy in elderly patients: the role of pharmacists.Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial.Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life.The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.Does the "script" need a rewrite? Is medication advice in television medical dramas appropriate?

P2860

Q26772198-844E1D63-91E7-445F-BE9D-36642B00D3C2 Q26786031-31DD5D30-48F2-45A0-AA64-FD62E0B01E2E Q30240726-1097F900-8503-450A-BC79-071E3B9970BB Q30745347-1CF75AD0-5ABA-4704-8450-DDBE4FBBFF5A Q33632515-112B5B37-73E5-47E1-8360-B8436CF366DC Q33730162-8F989C11-3EF2-4D10-B9EE-8A347F18EA23 Q34635492-3765D6A3-07C0-472D-BB33-9417B9EA32AF Q35868070-A28EAD82-3528-416E-812B-4B6AEA30AAA5 Q36037342-2E33E1FD-01CF-47E0-8552-025A8BC0405C Q36053099-90F4D97F-8BD9-43B8-A770-86EDF148812B Q36201114-633F59F4-CD10-4070-A22F-832C7240D8B6 Q36256416-6D17B57C-E144-40E2-8272-6AD6F6CECA07 Q36277670-D0A3C6D4-43C2-4BD0-95A8-2F9B682D86CE Q36416657-EE197A87-040E-43A3-8AF2-24A2AA1CF144 Q37103600-24476504-A735-43F2-A8AA-7533097EB5FF Q37384476-9DB5AA53-41C8-4696-87BD-FC62719C1537 Q38314127-5711BD2B-A504-4EB7-BF03-D06A5A04844D Q38369916-6F42526B-89BB-4823-9945-CF58D9E731C3 Q38387857-8EA7B1ED-145F-46D9-A89E-B00D3DF2A98C Q38792160-9A60E07D-7D4B-4601-979A-55EB391F9CE7 Q38874628-A9F5B9DE-C16B-48D9-B27F-8AEFEED8409F Q41987549-CFF78615-E290-4360-9065-F86947E202E1 Q43177166-AF5BC2BE-8A9F-4248-8C8E-7B2BC0BE2B6A Q45328140-F43216F4-E87C-46DF-B66B-5680803F6D4C Q46054816-F7AD7675-9AFA-4B43-9DFB-14F0C6D12C24 Q47149521-D76FB143-76E8-4861-A970-440B53555EA2 Q47249315-11735106-4D02-48C4-9AD2-0C84D7BB3080 Q47793990-F054B87A-24D1-4E69-AA08-1B59FD13398F Q47852723-9B655C27-0A7C-413A-A86C-4CC7D6286CD9 Q48123772-7C16F44D-EC74-4C9C-9FF1-7F4C8178C88C Q48139674-0B708EAD-91A7-4EE6-A290-5C36DEFC5EAA Q48222599-4B083C44-1F82-473A-A334-127515908CF1 Q48275843-3CF93AEB-28B7-4FB4-8048-D432934DFA79 Q49234428-AEE3B1D6-34D9-44C3-A7C3-239DFBB3B974 Q49324777-7CFDEF6B-1F3E-4D9A-B760-5AF4DD3DD02B Q49453635-4DD81C70-D0A0-4FFD-AFDE-CC75A7B14146 Q49792621-D562EEFE-70FD-4AA6-A058-1D17807E6E14 Q50001981-A9326010-A2F9-440E-8061-0E670DB84747 Q50056816-69BFF69E-B2B0-4B52-9111-BCCBC93EF07A Q50497434-A575B3DE-1874-40B1-BDE2-5097D5363440

P2860

Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q34297241

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Improving blood pressure contr ...... randomized controlled trials.

@ast

Improving blood pressure contr ...... randomized controlled trials.

@en

Improving blood pressure contr ...... randomized controlled trials.

@nl

type

label

Improving blood pressure contr ...... randomized controlled trials.

@ast

Improving blood pressure contr ...... randomized controlled trials.

@en

Improving blood pressure contr ...... randomized controlled trials.

@nl

prefLabel

Improving blood pressure contr ...... randomized controlled trials.

@ast

Improving blood pressure contr ...... randomized controlled trials.

@en

Improving blood pressure contr ...... randomized controlled trials.

@nl

P1433

Q34297241-D5AD5192-3335-437D-97F3-ABA6B3DFCD22

P1476

Q34297241-3BBB5D10-6D53-419D-B84D-958E9CAE0BCA

P2093

Q34297241-03FD68F3-7040-4967-9ED5-4D49F2FE0920

Q34297241-0A394461-E02B-410C-A4B5-4E15EB812B83

Q34297241-327618FB-8392-401E-B8CA-C5050A1E428C

Q34297241-7906E337-CC74-43E8-B852-F483BC8B04B8

Q34297241-80DD627C-9FFA-4BBC-9624-49209CCAD2C2

Q34297241-8593344F-84EB-4AE8-AB55-5B392A87A674

Q34297241-DA784E1A-30CE-4FC9-9049-49F331B13CDD

P275

Q34297241-6F55503A-8942-4934-982B-5918842D2772

P2860

Q34297241-12861998-C500-4C6D-A432-C9657822A810

Q34297241-1794209C-CD61-4311-8CC6-6A6D5DD69A33

Q34297241-1CAF4037-8D99-4922-BC09-EAECBB1D04CB

Q34297241-23AF57AE-E1CA-4E01-97CA-72C774B2DCCE

Q34297241-35824B88-B943-4C47-8A51-B555C486508B

Q34297241-48D8FC99-B8E4-467A-BFF6-DB7A12ACB39A

Q34297241-4D85E72B-87FA-4C59-9227-C97546768128

Q34297241-5B0BA576-51F9-4CA2-A1E3-8A539C168C01

Q34297241-60E27230-F11B-4588-9242-EA69ABA91CAE

Q34297241-627672F9-5F96-42AD-9142-05C1EB80AD57

P304

Q34297241-7C0B8386-6C64-421D-83DA-381EFBD544CF

P31

Q34297241-3BFF1DE3-8FFB-42C4-B9ED-AEEC6F5AE8B1

Q34297241-47f30b91-8e5f-4f41-b878-7567f05dfaf4

P356

Q34297241-B05219DC-F034-4A76-BF2E-BFB16383804B

P433

Q34297241-9C04D060-1030-4DD5-9F94-397D5312BC87

P478

Q34297241-C4AF03B5-CBC8-4B36-88BD-22E6B98366CC

P50

Q34297241-032040DE-4744-4402-B7A0-E7BC406583F8

P5008

Q34297241-1A97D46D-569D-4C3A-910F-5F91E98A150C

P577

Q34297241-E9E74D91-857B-459D-A8F0-D807A6C32FCE

P698

Q34297241-50F90806-ABAD-4856-A1C4-EF6496A7F41C

P921

Q34297241-C8EFE229-E814-43C7-AA6D-EACE3C89CBA0

Q34297241-FF2391B5-FFF6-4D61-A46E-783BCA9A7BA2

P932

Q34297241-6BA74153-9AA9-4A41-BF98-A15D17C2E4DC

P356

JAHA.113.000718

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Improving blood pressure contr ...... f randomized controlled trials

@en

P2093

April L Colosimo

http://www.w3.org/2001/XMLSchema#string

Bernard Burnand

http://www.w3.org/2001/XMLSchema#string

Gilles Paradis

http://www.w3.org/2001/XMLSchema#string

Michel Burnier

http://www.w3.org/2001/XMLSchema#string

Patrick Taffé

http://www.w3.org/2001/XMLSchema#string

Robert W Platt

http://www.w3.org/2001/XMLSchema#string

Valérie Santschi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Blood pressure lowering efficacy of loop diuretics for primary hypertension

The case of the misleading funnel plot

A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes

Meta-analyses: with confidence or prediction intervals?

Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.

Physician and pharmacist collaboration to improve blood pressure control

Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Hypertension treatment and control in five European countries, Canada, and the United States.

Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.

P304

e000718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.113.000718

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Arnaud Chiolero

P5008

P577

2014-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24721801

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4187511

http://www.w3.org/2001/XMLSchema#string